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Abstract: Although hypoxia is known to contribute to several aspects of tumour progression,
relatively little is known about the effects of hypoxia on cancer-associated myofibroblasts (CAMs),
or the consequences that conditional changes in CAM function may have on tumour development
and metastasis. To investigate this issue in the context of gastric cancer, a comparative multiomic
analysis was performed on populations of patient-derived myofibroblasts, cultured under normoxic
or hypoxic conditions. Data from this study reveal a novel set of CAM-specific hypoxia-induced
changes in gene expression and secreted proteins. Significantly, these signatures are not observed
in either patient matched adjacent tissue myofibroblasts (ATMs) or non-cancer associated normal
tissue myofibroblasts (NTMs). Functional characterisation of different myofibroblast populations
shows that hypoxia-induced changes in gene expression not only enhance the ability of CAMs
to induce cancer cell migration, but also confer pro-tumorigenic (CAM-like) properties in NTMs.
This study provides the first global mechanistic insight into the molecular changes that contribute to
hypoxia-induced pro-tumorigenic changes in gastric stromal myofibroblasts.
Keywords: cancer-associated myofibroblasts; hypoxia; tumour microenvironment; gene expression;
secretome; transcriptomics; proteomics; gastric cancer; omics
1. Introduction
Gastric cancer remains a leading cause of cancer death worldwide [1]. It is now clear that
many tumours develop as a result of complex reciprocal interactions between cancer cells and
neighbouring cells within the tumour microenvironment. These include fibroblasts, myofibroblasts,
endothelial cells, and immune cells, which together contribute to the formation of a specialised
extracellular matrix, and soluble paracrine factors [2,3] which support the growth and metastasis of
gastric tumours. In contrast to many other tissues, ‘activated’ myofibroblasts are well represented
in normal gastric tissue, where they are closely allied to the epithelium. However, in gastric
cancers, resident myofibroblasts acquire additional tumour promoting functions [4]. In particular,
gastric cancer-associated myofibroblasts (CAMs) secrete factors that increase the migration, invasion,
and proliferation of cancer cells, when compared to either adjacent tissue myofibroblasts (ATMs),
or normal tissue myofibroblasts (NTMs) [5]. This tumour-promoting phenotype is maintained,
at least in part, due to a robust CAM-specific DNA methylation signature [6]. Analysis of gastric
CAM conditioned media confirmed that these cells exhibit distinct patterns of protein secretion,
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compared to tissue matched ATMs. Further, a direct correlation was observed between decreased
levels of extracellular matrix adaptor proteins, such as transforming growth factor β-induced
gene-h3 (TGFβig-h3) in the secretome of gastric CAMs and the occurrence of lymph node metastasis,
worse prognosis, and shorter patient survival times [5].
Significantly, a number of other factors that distinguish gastric CAMs from normal non-cancer
associated myofibroblasts have been reported. One such factor is galectin-1, which shows increased
expression in CAMs and was shown to enhance gastric cancer cell migration and invasion by
upregulating integrin-β1 expression [7]. In addition, CAM-derived galectin-1 is also known to promote
angiogenesis in gastric cancer [8]. Other examples of CAM specific changes include the upregulation of
miR-106b and fibroblast growth factor 9 (FGF-9) [9,10]. FGF-9 promotes the anti-apoptotic and invasive
capability of gastric cancer cells [9], whereas upregulated miR-106b is associated with poor patient
prognosis, as it enhances gastric cancer cell migration and invasion [10]. Immunohistochemistry
and real-time PCR experiments have shown that CAMs frequently accumulate in the stroma of
gastric tumours, and the prevalence of CAMs shows a positive correlation with tumour size, depth,
and metastasis [11]. Interestingly, studies in scirrhous gastric cancer, which has the worst prognosis
among all types of gastric cancer, show that CAMs may also regulate the stemness of cancer stem
cells (CSCs) [12], identifying Asporin as a unique CAM-derived secretory protein that promotes the
coordinated invasion of both CAMs and cancer cells [13].
As CAMs play a vital role in the progression of gastric cancer, it is critical to define the molecular
mechanisms that enable gastric CAMs to facilitate different aspects of tumour progression. This study
was designed to compare the molecular modulation of different myofibroblasts populations (CAM,
ATM, NTM) in response to hypoxic conditions.
Hypoxia is an important microenvironmental factor which contributes to several aspects of tumour
progression, including tumour growth, tissue invasion, and metastatic spread [14,15]. Although
significant efforts have been devoted to studying the consequences of hypoxia on cancer cells, relatively
little is known about the effects or consequence of hypoxia on the stromal component of the tumour
microenvironment. Previously, it was proposed that hypoxia may have a role in modulating the
differentiation and activity of stromal cells [16] in such a way that they synergise with hypoxic oxidative
stress to enhance tumour aggressiveness in melanomas [17]. In this context, hypoxia-mediated
oxidative stress was found to be mandatory for the activation of dermal fibroblasts and secretion
of cytokines and other pro-migratory factors, in addition to actively promoting the invasion and
chemotaxis of melanoma cells [17]. However, the extent to which exposure to hypoxia may contribute
to or change myofibroblast activity in gastric cancer remains largely unexplored. For example, it is not
yet known if hypoxia induces a more aggressive CAM phenotype, or if NTMs become more aggressive,
or more CAM-like, under hypoxic conditions. Equally, little is known about the induced conditional
changes in gene expression that may facilitate pro-tumorigenic changes in myofibroblasts, including
changes in the secretome of CAMs or NTMs, which in turn may have the potential to impose changes
in cancer cell function.
To address these questions, we employed a combination of cell-based assays and genomic,
transcriptomic, and proteomics approaches. Results from this study show that hypoxia enhances
CAM-induced cancer cell migration and promotes the acquisition of CAM-like properties in NTMs.
Furthermore, our data identify unique gene expression and protein secretion signatures between
myofibroblasts purified from different tissue microenvironments, thereby providing a new resource
to guide mechanistic investigation into the molecular processes that drive key aspects of tumour
stromal communication.
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2. Results
2.1. Hypoxia Enhances CAM-Induced Cancer Cell Migration and Promotes CAM-Like Properties in NTMs
To assess how hypoxia (1% O2) may affect the ability of CAMs and NTMs to induce cancer cell
migration and/or proliferation, a series of complementary Boyden chamber migration and EdU cell
proliferation assays were performed, in which gastric adenocarcinoma cells (AGS) were exposed to
fresh CAM or NTM conditioned media (CM), prepared under hypoxic (hypoxic-CM) or normoxic
(ctrl-CM) conditions. Results from these studies show that both CAM- and NTM-derived hypoxic-CM
significantly enhanced the migration of gastric cancer cells, in comparison to corresponding ctrl-CM
derived from either CAMs or NTMs (Figure 1A, Figure S1A). These data confirm that hypoxia induces
the expression and release of pro-migratory factors. Interestingly, group mean data show this effect is
on average almost twice as large for CAM-hypoxic-CM, as compared to NTM-hypoxic-CM (Figure 1B).
By contrast, hypoxia exerted a reciprocal trend with respect to gastric cancer cell proliferation.
Compared to ctrl-CM, CAM-hypoxic-CM consistently reduced gastric cancer cell proliferation,
while NTM-hypoxic-CM induced a reproducible increase in cancer cell proliferation (Figure 1C,
Figure S1B). On average, exposure to hypoxia conferred a ~40% decrease in CAM-stimulated cancer
cell proliferation, in contrast to a ~30% hypoxia-induced increase in NTM-stimulated cancer cell
proliferation (Figure 1D). Together, these results suggest that hypoxic conditions may promote some
CAM-like properties in gastric NTMs. In particular, exposure to hypoxic conditions would allow
non-cancer conditioned NTMs within the surrounding stroma to contribute to hypoxia-enhanced
proliferation and spread of metastatic gastric cancer cells. To investigate the molecular mechanisms
that confer hypoxia-induced changes in different myofibroblast populations, a comparative global gene
expression analysis was performed on patient-matched gastric CAMs and ATMs, and unrelated NTMs.
2.2. Hypoxia Confers Differential Changes in Gene Expression in Gastric Myofibroblasts Purified from Different
Tissue Microenvironments
To compare hypoxia-induced gene expression signatures in gastric myofibroblasts purified
from different tissue microenvironments, Illumina HumanHT-12v4 Expression BeadChip arrays
were performed on a collection of patient-matched CAM and ATM samples and unrelated NTM
samples. In each case, myofibroblasts were cultured in parallel under either hypoxic (1% O2) or
normoxic (21% O2) conditions for 72 h. Overall, 13381 genes were consistently expressed in all
samples. Of those, 2467 genes were found to be differentially expressed in hypoxic CAMs compared
to control CAMs (Figure 2A). In comparison, 2722 genes were found to be significantly altered in
hypoxic vs. normoxic NTMs (Figure 2B), and 2561 genes were differentially expressed in hypoxic vs.
normoxic ATMs (Figure 2C). Notably, unsupervised hierarchical clustering correctly grouped samples
by condition and identified clear clusters of genes, which reflect transcriptome remodelling in response
to hypoxia (Figure 2).
2.2.1. Differential Hypoxia-Induced Myofibroblast Phenotypes Are Not Due to Changes in
DNA Methylation
To assess whether observed changes in hypoxia-induced gene expression profiles are the result of
conditional changes in DNA methylation, parallel Illumina Infinium HumanMethylation450 BeadChip
assays were performed on CAMs, patient-matched ATMs, and unrelated NTMs. Comparison of
genome–wide DNA methylation profiles between: (i) CAM hypoxia vs. CAM normoxia, (ii) ATM
hypoxia vs. ATM normoxia, and (iii) NTM hypoxia vs. NTM normoxia showed a striking similarity in
DNA methylation profiles between matched hypoxic and normoxic samples. In all three comparisons,
no significant methylation changes were observed. For clarity, this is visualised in a single volcano
plot and scatter plot in Figure 3A,B. These data suggest that under the conditions used in this
study, hypoxia-imposed changes in gene expression are not conferred by associated changes in DNA
methylation patterns.
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Figure 1. Differential effects of cancer-associated myofibroblasts (CAM) and normal tissue 
myofibroblasts (NTM) hypoxic conditioned media (CM) on gastric adenocarcinoma cell (AGS) 
migration and proliferation. (A,B). CAM-hypoxic-CM (magenta) and NTM-hypoxic-CM (blue) 
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Individual patient data corrected for AGS basal migration (serum-free media) normalised to 
Fig re 1. Differential effects of ca cer-associated yofibroblasts ( ) a or al tiss e
yofibroblasts ( T ) hypoxic conditioned edia ( ) on gastric adenocarcino a cell ( S)
igration and proliferation. ( ,B). C -hypoxic-C ( agenta) and T -hypoxic-C (blue)
induce S cell migration compared to respective CAM or NTM normoxic-control CM (grey).
(A) Individual patient data corrected for AGS basal migration (serum-free media) normalised
to respective patient-specific control CM obtained from normoxia (expressed as 100% to enable
comparison between effects of CAM and NTM hypoxic conditioned media on AGS migration;
for pair-wise comparisons between respective patient-specific ctrl- and hypoxic-CM, see Supplementary
Figure S1A); paired t-test p-value < 0.0001. Error bars represent SD of technical replicates. (B) Group
mean data (biological replicates) of AGS cell migration in response to hypoxic-CM from CAMs (n = 3)
and NTMs (n = 3); unpaired t-test p-value > 0.05; Error bars represent SEM. (C,D). NTM-hypoxic-CM
(blue) induces AGS cell proliferation, whereas CAM-hypoxic-CM (magenta) reduces the ability of
AGS cells to proliferate compared to respective CAM or NTM control CM (grey) obtained from
normoxia. (C) Individual patient data corrected for AGS basal proliferation (serum-free media) and
normalised to respective patient-specific control CM obtained from normoxia (expressed as 100% to
enable comparison between effects of CAM and NTM hypoxic conditioned media on AGS proliferation;
for pair-wise comparisons between respective patient-specific ctrl- and hypoxic-CM, see Figure S1B);
paired t-test p-value < 0.005. Error bars represent SEM of technical replicates. (D) Group mean data
(biological replicates) of AGS cell proliferation in response to hypoxic-CM from CAMs (n = 3) and
NTMs (n = 3); unpaired t-test p-value < 0.005; Error bars represent SEM.
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hierarchical clust ing of the differentially expr ssed gen s (shown in black in volcano plots).
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Figure 3. Hypoxia-induced gene expression signatures are not conferred by associated changes in DNA
methylation. (A,B) Comparative global DNA methylation profiles of primary gastric myofibroblasts
following exposure to hypoxic or normoxic conditions. (A) Volcano plot showing significance versus
∆β values for 424383 methylation probes in the three hypoxia (CAM, ATM, and NTM; n = 9) vs.
normoxia (CAM, ATM and NTM; n = 9) comparisons. (B) Scatter plot representing mean β values for
normoxic (CAM, ATM and NTM; n = 9) and hypoxic (CAM, ATM, and NTM; n = 9) myofibroblasts.
Red dashed lines represent |∆β| > 0.2. (C,D). Comparison of hypoxia-induced gene expression
signatures identified in gastric CAMs, ATMs, and NTMs. (C) Venn diagram showing the overlap
between significantly changed genes (limma p-value < 0.05) in response to hypoxia in CAM, ATM,
and NTM cells. The common intersection represents a universal hypoxia-induced gene signature.
Unique CAM-, ATM-, and NTM- hypoxi -induced gene signatures re highlighted in bold. (D) Genes
universally changed in the same direction under hypoxia across all three populations of gastric
myofibroblasts (CAMs, ATMs, and NTMs, limma FDR p-value < 0.05).
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2.2.2. Hypoxia-Induced Gene Expression Signatures
In general, cells appear to respond to hypoxia via a common HIF-1α mediated mechanism [18,19];
therefore, a subset of common hypoxia-induced gene expression changes may be expected in all
populations of myofibroblasts. However, since the net functional response of each population
of myofibroblasts (CAMs, ATMs, or NTMs) is different, it is likely that reported variations in
epigenetic programming between different myofibroblast populations [6] may confer differences in
gene expression, and functional responses to hypoxic conditions. Differential gene expression analyses
identified 702 genes that are universally changed under hypoxia in all myofibroblast populations
(Figure 3C), including a subset of genes that exhibit conserved directional changes (p-value < 0.05)
across all myofibroblast types (Figure 3D). Amongst the most upregulated genes are AK4, PFKFB3,
BNIP3, and NDRG1, all of which show around 4-fold increases in expression under hypoxic conditions.
In comparison, genes displaying the largest down-regulation in response to hypoxia are GANAB,
SLC3A2, NQO1, and AIMP2 (FC < −2). To identify signalling pathways that are enriched in the
group of 702 universal hypoxia-induced genes, gene ontology (GO) and gene set enrichment (GSEA)
analyses were performed. Results from GO term analyses revealed glycolytic processes and metabolic
processes to be the most significantly represented (Figure S2). Reassuringly, GSEA analysis detected
strong enrichment of gene sets characteristic for hypoxic cells, with ‘hallmark hypoxia’ and ‘hallmark
glycolysis’ having the highest normalised enrichment scores. Notably, genes associated with those
categories were almost exclusively grouped in the fraction of hypoxia up-regulated genes (Figure S3
and Table S1).
2.2.3. CAMs, ATMs, and NTMs Express Unique Gene Signatures Under Hypoxia
Although common patterns of hypoxia-induced gene expression were observed in all populations
of gastric myofibroblasts, functional assays confirmed that each population conferred differential effects
on cancer cell migration and proliferation following exposure to hypoxic conditions. To investigate
the molecular basis of these functional differences, subsets of unique hypoxia-induced genes were
identified in each myofibroblast population. In total, 894 genes were found to be uniquely changed in
hypoxic CAMs, 1171 in hypoxic NTMs, and 1073 in hypoxic ATMs (Figure 3C). Each of these distinct
conditional response signatures was then subjected to functional enrichment analysis using GO (Table
S2), GSEA (Figure S4 and Table S3), and ingenuity pathway analysis (IPA, Figure S5).
Overall, these analyses revealed unique transcriptional responses to hypoxia across different
populations of myofibroblasts. Most notably, upregulation of ‘cholesterol biosynthesis’ and ‘fatty acid
metabolism’ emerged as a unique feature of hypoxic CAMs, while GSEA showed enrichment for
‘hallmark cholesterol homeostasis’ (Figure S4A). In addition, IPA revealed an upregulation of nearly
all components of the ‘superpathway of cholesterol biosynthesis’ (Figure S5). These data strongly
suggest that hypoxia enhances production of cholesterol in gastric CAMs, which may contribute
to the energy metabolism of adjacent cancer cells. Notably, in patient-matched ATMs, low oxygen
concentration uniquely induced the expression of genes involved in the G2/M cell cycle checkpoint,
mitotic spindle assembly, and integrin signalling (Figures S4B and S5, Tables S2 and S3). Finally,
analysis of the NTM unique gene expression signature showed that these genes simply contribute
to signalling pathways related to hypoxia response and xenobiotic metabolism (Figures S4C and S5,
Tables S2 and S3). The IPA downstream effects analysis, which facilitates the prediction of functions
and processes that are expected to be increased or decreased based on changes in gene expression,
also complements these observations (Figure S6).
Having identified prominent population-specific differences in myofibroblast responses to hypoxic
conditions, it was important to investigate if factors secreted by hypoxic CAMs and NTMs could be
predicted, based on changes in gene expression. Therefore, an IPA downstream effects analysis was
performed for CAM-hypoxia vs. CAM-normoxia and NTM-hapoxia vs. NTM-normoxia comparisons.
The results were then filtered to include only genes that were likely to encode extracellular proteins
that may be involved in cell migration and proliferation. This procedure identified 66 pro-migratory
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and pro-proliferative proteins that are likely to affect the observed cancer cell phenotype in response
to CAM- and NTM-hypoxic-CM (Figure 4A,B).
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Figure 4. Unique CAMs and NTMs hypoxia signatures may explain differential effects on cancer cell
phenotype. (A,B). Predicted pro-migratory and pro-proliferative factors secreted by hypoxic CAMs and
hypoxic NTMs. (A). Extracellular molecules expressed by hypoxic CAMs. (B). Extracellular molecules
expressed by hypoxic NTMs. Molecules displayed in boxes are uniquely expressed in hypoxic CAM
or hypoxic NTM. (C,D). Volcano plots of differentially secreted proteins in (C). CAM-hypoxic-CM vs.
CAM-ctrl-CM and (D). NTM-hypoxic-CM vs. NTM-ctrl-CM comparisons. Proteins highlighted in red
were annotated as secreted/extracellular or identified in exosomes based on MetazSecKB, Matrisome,
and ExoCarta searches. Proteins above the line (p-value < 0.05) are considered to be differentially
secreted between the given conditions.
2.3. Analysis of Hypoxia-Induced CAM and NTM Secretomes
In order to compare the profile of secreted proteins released by gastric myofibroblasts in
response to hypoxia, conditioned media from CAMs and NTMs were p ofiled using liquid
chromatograp -mass spectrometry (LC-MS). In total, four conditions were xamin : (i) CAM-ctrl-
CM; (ii) CAM- poxic-CM; (iii) NTM-ctrl-CM; and (iv) NTM-hypoxic-CM. In each case, C was
collected after 72 h exposure to hypoxic (1% O2) or normoxic (21% O2) conditions. Altogether,
1169 protein groups were id ntified (FDR p-value < 0.01) and quantified across all sampl s (n = 2)
using the MaxQuant computational platform. A core of 702 prote ns was detected in all CM samples.
T se were subjected to ge e ontol gy (GO) enrichment analysis using the PANTHER classification
system [20] in order to verify their c llular location. The identified proteins were significantly
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enriched in terms of annotation for extracellular region (p = 4.59 × 10−227) and extracellular vesicle
(p = 1.74 × 10−200). The other top 10 most significantly enriched GO terms were also associated with
extracellular structures, confirming that our experimental strategy worked. In addition, the Metazoa
Secretome and Subcellular Proteome Knowledge Base [21], MatrisomeDB [22], and ExoCarta [23] were
used to further annotate proteins identified in CAM or NTM secretomes. Overall, 76% were either
known or predicted to be extracellular (Figure S7).
2.4. Gene Expression Profiles Enable Prediction of Secreted Factors
Following an analysis of variance (ANOVA) test, a number of differentially secreted proteins
were identified: 43 in the CAM-ctrl-CM vs. CAM-hypoxic-CM comparison (Figure 4C) and 225 in
NTM-ctrl-CM vs. NTM-hypoxic-CM comparison (Figure 4D). However, only 14 (5%) of all significantly
changed proteins were altered in both hypoxic NTM and CAM secretomes (Figure S8). This reinforced
our previous findings that different populations of myofibroblasts display unique molecular signatures
in response to environmental changes. Significantly, proteomics analysis also confirmed some
conditional secretome signatures that were predicted from the analysis of corresponding gene
expression profiles (Figure 4A,B). In particular, gelsolin (GSN), vascular endothelial growth factor A
(VEGFA), and glucose-6-phosphate isomerase (GPI) were all verified at protein level to be differentially
secreted by both hypoxic CAMs and NTMs (Figure 5A). In addition, hypoxic NTMs increased secretion
of lysyl oxidase (LOX), insulin-like growth factor-binding protein 3 (IGFBP3), insulin-like growth
factor-binding protein 6 (IGFBP6), and angiopoietin-related protein 4 (ANGPTL4). Furthermore,
secretion of those proteins was not significantly altered in hypoxic CAMs (Figure 5B,C), as predicted
by IPA. This demonstrates that integration of multiple omics technologies enables validation of results,
while also facilitating biologically relevant predictions.
Another finding in concordance with previous gene expression studies relates to the potential
biological effects of the secreted proteins. IPA downstream effects analysis indicated that cell death
and necrosis may decrease in response to hypoxia-induced changes in CAM secretome composition.
Furthermore, proliferation, invasion of tumour cell lines, and angiogenesis were predicted to increase
in response to imposed changes in the NTM hypoxia-induced secretome (Figure S9). Notably, proteins
secreted by hypoxic NTMs were predicted to be regulated by HIF-1α activation (z-score = 2.303,
p = 4.76 × 10−9), as revealed by IPA upstream regulator analysis. These hypoxic NTM secreted
proteins positively affect angiogenesis, migration of endothelial cells, and proliferation of tumour
cell lines (Figure S10). These results provide new insights into the potential mechanisms by which
hypoxia may enable stromal myofibroblasts to promote cancer cell proliferation and migration as well
as highlighting the molecular components involved in mediating these processes.
2.5. Secretion Is Not Strongly Regulated by Transcriptome Changes
Although likely secreted factors can be predicted from gene expression data, the extent to which
transcriptomic profiles reflect true patterns of protein expression or secretion remains uncertain.
Nevertheless, on a simplistic level, it is possible that in some cases, increased mRNA expression may
lead to higher concentrations of the encoded proteins and enhanced levels of secretion, or vice-versa.
To identify subsets of proteins which show this correlation, fold changes of differentially expressed
genes were compared with corresponding measurements of secreted proteins. For each comparison,
a Pearson correlation coefficient (r) was calculated and the significance of the relationship was
assessed by obtaining the corresponding p-value. Overall, a statistically significant correlation was
observed between these two variables. In CAMs, the transcriptome showed a weaker yet significant
correlation with the secretome (r = 0.42), while in NTMs, the co-regulation was substantially higher
(r = 0.6) (Figure 5D). Furthermore, in both cases, the correlation was positive, indicating that on
average, increases in transcript concentration lead to greater protein secretion in response to hypoxia.
In addition, the magnitude of the changes was also similar.
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3. Discussion
Hypoxia is an important microenvironmental factor in the development and metastasis of many
solid tumours. During tumour development, both cancer and stromal cells are exposed to hypoxic
conditions. This study provides novel evidence that hypoxia induces differences in the functional
effects that gastric CAMs and NTMs exert on cancer cell migration and proliferation. In particular,
hypoxia significantly increases the ability of CAMs to promote the migration of cancer cells, while also
inducing pro-tumorigenic CAM-like properties in gastric NTMs. Genome-wide DNA methylation
profiling of hypoxia-treated CAMs and NTMs showed that although CAMs and NTMs have distinctive
patterns of DNA methylation [6], these characteristic profiles were not significantly altered by hypoxic
conditioning, suggesting that unique transcriptional responses to hypoxia observed among different
populations of gastric myofibroblasts (CAMs, ATMs, NTMs) most likely stem from differential retained
epigenetic backgrounds. As such, hypoxia, as a single microenvironmental factor, is unlikely to impose
CAM-like DNA methylation patterns in normal tissue myofibroblast (NTMs).
Interestingly, upregulation of cholesterol biosynthesis and fatty acid metabolism emerged as
a unique feature of hypoxic CAMs, with all components of the “superpathway” for cholesterol
biosynthesis showing significant upregulation, indicating that hypoxia may enhance cholesterol
production in gastric CAMs. In this context, malignant cells have previously been shown to increase
lipolysis in adipocytes, which then secrete fatty acids that are then taken up by neighbouring cancer
cells to enhance energy production [24]. Data from this study suggest that under hypoxic conditions,
gastric CAMs may serve a similar function. In particular, coupling of energy metabolism between
CAMs and cancer cells may be mediated by fatty acid binding proteins, such as FABP1 and FABP3,
which were also upregulated in hypoxic CAMs. Finally, upregulation of cholesterol biosynthesis
under hypoxia in CAMs may serve as an adaptive mechanism that protects CAMs from oxidative
damage. Activation of de novo lipogenesis in cancer cells leads to increased membrane lipid saturation,
resulting in higher levels of saturated and monounsaturated phospholipids, which may protect cancer
cells from free radicals and chemotherapeutics [25].
Transcriptional analysis of the unique gene set identified in hypoxic NTMs shows a more classic
response, mainly composed of genes known to contribute to hypoxic signalling pathways, hypoxia
response, and xenobiotic metabolism.
The IPA downstream effect analysis performed in this study predicts distinct biological effects
of hypoxia among different gastric myofibroblast populations. Significantly, activation of autophagy
emerged as a key CAM-specific process that was enhanced in response to hypoxia, whereas processes
such as organisation of organelle, growth of microtubules, and aneuploidy of cells appeared to be
activated only in hypoxic ATMs, while expression and transcription of RNA were the most significantly
activated processes in hypoxic NTMs. Interestingly, processes such as mitosis, angiogenesis, invasion
of cells, growth of axons, neoplasia of tumour cell lines, and glycolysis of cells were all predicted to be
most active in hypoxic NTMs.
Secretome analysis confirmed some of the predictions based on hypoxia-induced CAM and NTM
gene expression profiles. Interestingly, lysyl oxidase (LOX), among others, was verified at the protein
level as an NTM unique hypoxia-induced secreted protein. LOX is an extracellular amine oxidase that
post-translationally modifies collagens and elastin in the extracellular matrix, catalysing the covalent
crosslinking of fibres [26], thus contributing to hypoxia-induced metastasis. LOX is highly expressed
in hypoxic tumour cells, including breast cancer, where it promotes extracellular matrix remodelling
in the lungs, leading to the formation of a metastatic niche [27]. Comparative analysis of secretomes
and gene expression profiles revealed that both expression and secretion of LOX is increased in CAMs
compared to NTMs under normal conditions. However, when oxygen is limited, LOX is also induced
in NTMs, both at the mRNA and protein level.
Comparative profiling of the secretomes of hypoxic CAMs, compared to control CAMs or hypoxic
and control NTMs, shows that hypoxia has a significantly greater impact on protein secretion in NTMs
than CAMs. This observation is also consistent with IPA downstream effect analysis, which predicts
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that expression and transcription of RNA is the most significantly activated processes in hypoxic
NTMs. Taken together, these data suggest that CAMs are somehow less responsive to low oxygen
levels then NTMs.
Proteins differentially secreted by NTMs in response to hypoxia were predicted to be regulated
by HIF-1α activation and are known to enhance tumour cell proliferation, invasion, cell movement,
angiogenesis, vasculogenesis, and the migration of endothelial cells. Significantly, these data are
consistent with experimental data presented in this study, showing increased cancer cell migration
and proliferation in response to NTM-hypoxic-CM compared to NTM-ctrl-CM. By contrast, proteins
differentially secreted by hypoxic CAMs, compared to control CAMs, were predicted to reduce cell
death via necrosis or apoptosis. Taken together, these results concur with gene expression analysis of
hypoxia-induced NTM- and CAM-specific gene signatures.
In summary, this study is the first to perform comparative multi-omics profiling to investigate the
global effects of hypoxia on DNA methylation, gene expression, and protein secretion in populations of
primary gastric myofibroblasts, derived from either cancer (CAMs), pre-neoplastic (ATMs), or normal
(NTMs) tissue. Data presented in this study provide new insight into the differential molecular
responses of myofibroblasts to hypoxic conditions within the gastric tumour microenvironment.
The integrated multi-omic data sets from this work will act as a resource to inform future studies into
the molecular mechanisms of tumour progression, while also facilitating comparative analysis of the
effects of hypoxia on myofibroblast function in the microenvironment of other solid tumours.
4. Materials and Methods
4.1. Primary Gastric Myofibroblasts
Human primary gastric myofibroblasts were derived as previously described [28]. In each case,
isolated myofibroblast populations were analysed to confirm stellate/spindle-shaped morphology and
consistent expression of both α-SMA and vimentin, as shown previously [5]. Primary myofibroblast
cultures were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10%
foetal bovine serum (FBS), 1% penicillin–streptomycin, 1% antibiotic–antimycotic, and 1% non-essential
amino acid solution. Medium was replaced every 48–60 h. In all cases, myofibroblasts were not
maintained beyond passage 12.
4.2. Gastric Cancer Cell Culture
Human gastric adenocarcinoma cells (AGS) were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% foetal bovine serum (FBS), 1% penicillin–streptomycin, and 1%
antibiotic–antimitotic solution. The AGS cells were incubated at 37 ◦C in a humidified atmosphere
with 5% CO2 and were passaged or growth media were changed approximately every 48–72 h. In all
experiments, cells were used between passages 18 and 28.
4.3. Hypoxic Conditioned Media Preparation
In order to generate CAM or NTM hypoxic conditioned media (CAM-hypoxic-CM or
NTM-hypoxic-CM) and CAM or NTM normoxic conditioned media (CAM-ctrl-CM or NTM-ctrl-CM),
5 × 105 of selected myofibroblast cell lines were seeded in 75 cm2 flasks and left attached for 24 h in
growth media. The next day, the media were replaced, and cells were put either to normoxia (21%
O2) or hypoxia (1% O2) for 48 h incubation in serum-supplemented DMEM. After 48 h, the cells were
washed three times in 1× PBS to get rid of any serum-derived factors, and 13 mL freshly prepared
serum-free DMEM supplemented with 1% penicillin–streptomycin, 1% antibiotic–antimycotic, and 1%
non-essential amino acid solution was added to the cells. The serum-free media were incubated with
the cells for 24 h in normal (21% O2) and hypoxic (1% O2) conditions. The following day, myofibroblast
ctrl-CM and hypoxic-CM were collected and centrifuged at 800g for 7 min to remove cell debris.
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The freshly prepared CAM or NTM hypoxic-CM and ctrl-CM were immediately used for cancer cell
migration and proliferation assays.
4.4. Cancer Cell Migration Assay
The effects of hypoxic-CAM and hypoxic-NTM conditioned media (CM) on gastric cancer cells
migration were measured in vitro using trans-well Boyden chamber assay (SLS; cat. no. 354578).
Briefly, 1 × 104 AGS cells in 500 µL of serum-free DMEM medium were added to the BioCoat Control
Inserts with 8µm pore PET membrane (upper chambers). The lower chambers contained either 750 µL
serum-free media, or myofibroblast CM to serve as a chemoattractant. Cells were incubated at 37 ◦C
and allowed to migrate overnight. Thereafter, AGS cells were removed from the upper surface of
the membrane by scrubbing with cotton swabs. Cells migrating through the membrane were fixed
and detected on the lower surface using Reastain Quick-Diff Kit (Reagena; cat. no. 102164, Toivala,
Finland) and then examined under a bright-field microscope. Values for cancer cell migration were
obtained by counting fifteen fields per membrane (20× objective) and represent an average of at least
three independent membranes.
4.5. Cancer Cell Proliferation Assay
The effects of hypoxic-CAM and hypoxic-NTM conditioned media (CM) on gastric cancer cell
proliferation were assessed by incorporation of 5-ethynyl-2′-deoxyuridine (EdU) [29] and detected
using the Click-iT EdU Alexa Fluor 488 Imaging Kit (Life Technologies; cat. no. C10337, California,
CA, USA). Briefly, 1 × 104 AGS cells were plated onto cover glasses in 24-well plate and left for 24 h at
37 ◦C to attach. The next day, growth media were replaced with serum-free DMEM supplemented
with 1% penicillin–streptomycin and 1% antibiotic–antimycotic to synchronise the cells. Thereafter,
the media were replaced with 1 ml of either serum-free media or myofibroblast CM containing 10 µM
EdU, and cells were incubated overnight at 37 ◦C, 5% CO2. Following incubation, the manufacturer’s
protocol was applied to fix and permeabilise the AGS cells and detect EdU incorporation.
4.6. Integrated Multi-Omics Myofibroblast Profiling
Gastric cancer patient-matched CAMs and ATMs (n = 3) as well as unrelated NTMs (n = 3) were
cultured in parallel for integrated genome-wide DNA methylation, gene expression, and secretome
profiling. In order to generate myofibroblast conditioned media, 500 × 103 of selected myofibroblast
cell lines were seeded in 75 cm2 flasks. Growth media were replaced after 24 h and cells were incubated
under normoxic (21% O2) or hypoxic (1% O2) conditions for 48 h. After this initial incubation, cells were
washed three times in 1× PBS to remove serum-derived proteins, and 13 mL of freshly prepared
serum-free DMEM supplemented with 1% penicillin–streptomycin, 1% antibiotic–antimycotic, and 1%
non-essential amino acid solution was added and conditioned for 24 h under normoxic or hypoxic
conditions. Conditioned media and cell lysates for DNA and RNA extraction were collected for
use in Illumina Infinium HumanMethylation450k and HumanHT-12v4 Expression arrays as well as
LC-MS/MS secretome analysis.
4.6.1. Illumina Human HT-12 v4 Array
Total RNA for gene expression analysis using the Illumina HumanHT-12v4 Expression BeadChip
arrays was purified using miRNeasy Mini Kit (Qiagen, cat. no. 217004, Hilden, Germany) according to
manufacturer’s instructions. RNA sample quality and quantity were assessed by spectrophotometry
at 260/280 nm. The Bioconductor package lumi (version 2.18.0) [30] was used to import the raw
intensities data into R and perform background correction, variance stabilisation transformation [31],
robust spline normalisation, and subsequent quality control. A biological replicate of one of the
samples was included to assess the reproducibility of sample preparation (R2 = 0.9933573). Probes with
a detection p-value < 0.01 across all samples were considered non-detectable and were removed
from analysis. Un-annotated probes were also removed, restricting the subsequent analysis to 18090
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probes (corresponding to 13381 genes; GEO accession number: GSE125177). To identify differentially
expressed transcripts in (i) CAM hypoxia vs. CAM normoxia, (ii) NTM hypoxia vs. NTM normoxia,
and (iii) ATM hypoxia vs. ATM normoxia comparisons, the Bioconductor package limma [32,33] was
used. The Benjamini and Hochberg method [34] was used to control for false discovery rate.
4.6.2. Illumina Infinium HumanMethylation450k Array
Genomic DNA for DNA methylation analysis using the Illumina Infinium HumanMethylation450
BeadChip arrays was purified using a standard phenol/chloroform extraction method. DNA sample
purity and extent of degradation were determined by spectrophotometry at 260/280 nm and gel
electrophoresis on 1% agarose gel, respectively. DNA quantity was assessed using PicoGreen
fluorimetry (Life Technologies, cat. no. Q-33130, California, CA, USA). Raw DNA methylation data
were processed and analysed using Bioconductor package RnBeads version 0.99.17 [35] as described
previously [6].
4.6.3. Secretome Profiling
Conditioned media from normoxic and hypoxic myofibroblasts were centrifuged at 800 g for 7
min to remove cell debris and supernatants were aliquoted and stored at −80 ◦C prior to LC-MS/MS
secretome analysis, which was performed by the Centre for Proteome Research (University of Liverpool,
Liverpool, UK). Raw mass spectrometry data were analysed using MaxQuant software [36] with
Andromeda [37] as a search engine against the reference human proteome (Uniprot proteome ID
UP000005640, containing 42112 reviewed canonical and isoform protein entries, accessed 30 April
2015) and 123 potential contaminants. Protein quantification was obtained using the MaxQuant
intensity-based label free quantification (LFQ) algorithm. Potential contaminants identified in the mass
spectrometry data were manually examined, and proteins associated with foetal bovine serum (FBS) or
trypsin were rejected. The LFQ algorithm extracts protein intensities form the raw data and performs
appropriate normalisation steps to allow between sample comparisons and remove any systematic
errors during data acquisition. For simplicity, the protein group was reported in all cases where a
protein was identified by peptides that could not be assigned to individual protein unambiguously,
for example, in cases of highly homologous proteins, or protein isoforms. On average, each protein was
quantified with 7 unique peptides and 22% sequence coverage was achieved. To compare CAM and
NTM secretomes from different microenvironmental conditions, four pair-wise comparisons were done
using a one-way analysis of variance (ANOVA) test as implemented in DanteR software [38]. Proteins
with a p-value < 0.05 were considered to be differentially secreted between the two conditions. The raw
mass spectrometry secretome data and processing results from MaxQuant have been deposited to the
ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner
repository [39] with the identifier PXD008104.
4.7. Gene Ontology Enrichment Analysis
Gene Ontology (GO) enrichment analysis [40] was performed on hypoxia-induced gene expression
profiles identified in CAMs, ATMs, and NTMs using GOrilla (gene ontology enrichment analysis
and visualization tool) [41]. The target genes were compared to the background gene set of all
expressed and normalised genes from the HT-12v4 Illumina experiment. The enriched GO terms in
individual CAM, ATM, and NTM hypoxia-induced gene expression profiles were discovered using a
hypergeometric model, p-value < 0.001 was applied, and the results were corrected for multiple testing
using the Benjamini and Hochberg method [34]. To reduce redundancy within the identified enriched
lists of GO terms, web server REVIGO [42] was used.
4.8. Gene Set Enrichment Analysis
Gene set enrichment analysis (GSEA v5.0) [43,44] was used to characterise and interpret the
identified unique-CAM, ATM, or NTM and universal hypoxia-induced gene expression profiles.
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The Molecular Signatures Database (MSigDB v5.0) [44] that contains collection of biologically
predefined gene sets was used to determine statistically enriched gene sets present in the analysed
gene expression data. The identified unique-CAM, ATM, or NTM and universal hypoxia-induced
gene expression profiles were separated into two phenotypes for GSEA: Hypoxia and normoxia.
For gene list ranking, multiple probes matching the same gene were sorted according to p-value,
and the probe with the lowest p-value was retained for the analysis. Genes were ranked using the
provided signal-to-noise ranking statistic, and GSEA was run using default weighted enrichment
statistics and evaluated for statistical significance by comparison to results obtained using 1000 random
permutations of each gene set. Default settings were used for all other GSEA parameters.
4.9. Ingenuity Pathway Analysis
Ingenuity pathway analysis (IPA) software was used to analyse and interpret the hypoxia-induced
gene expression profiles identified in CAMs, ATMs, and NTMs and hypoxia-induced CAM and NTM
secretome profiles. Gene expression profiles were compared against an IPA predefined Illumina
HT-12v4 reference set, whereas secretome profiles were compared against an Ingenuity Pathway
Analysis knowledge base (IKB). For gene expression data, an IPA canonical pathway and downstream
effects analyses were performed. For secretome data, IPA downstream effects and upstream regulator
analyses were performed. In each case, p-value was assigned using Fisher’s exact test, which indicates
the probability of overlap between the pathway/phenotype and input genes.
4.10. R/Bioconductor
R statistical software (version 3.1.2) and Bioconductor [45,46] were used to process and analyse
gene expression, DNA methylation, and secretome data.
5. Conclusions
This study shows that patient-derived gastric cancer-associated myofibroblasts (CAMs) exhibit
unique changes in gene expression and protein secretion in response to hypoxic conditions. Although
hypoxia increased production of factors involved in matrix remodelling in both CAMs and NTMs,
upregulation of factors required for cholesterol production and metabolism was only seen in CAMs.
These findings suggest that gastric CAMs, unlike patient-matched ATMs or NTMs, contribute to cancer
cell growth and metabolism. Functional studies show hypoxia increases the ability of gastric CAMs
to enhance cancer cell proliferation and migration, while also conferring pro-tumorigenic properties
in non-cancer derived NTMs. Conditional multi-omics data from this study will provide a resource
to facilitate future comparative studies to identify common mechanisms of tumour myofibroblast
interactions in other solid tumours.
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